Securities Code: 002399 Securities Abbreviation: Haipu Rui Announcement Number: 2026-010 Shenzhen Haipu Rui Pharmaceutical Group Co., Ltd. Announcement on the Election of the Board of Directors The Company and all members of the Board of Directors guarantee that the information disclosed is true, accurate, and complete, and that there are no false records, misleading statements, or major omissions. Shenzhen Haipu Rui Pharmaceutical Group Co., Ltd. (hereinafter referred to as the "Company")'s Sixth Board of Directors' term is about to expire. In accordance with the "Company Law," "Administrative Measures for Independent Directors of Listed Companies," "Stock Listing Rules of the Shenzhen Stock Exchange," and other laws, regulations, normative documents, and the "Articles of Association," the Company convened the 20th meeting of the Sixth Board of Directors on March 30, 2026. The meeting deliberated and passed the "Proposal on the Election of the Board of Directors and Nomination of Candidates for Non-Independent Directors of the Seventh Board of Directors" and the "Proposal on the Election of the Board of Directors and Nomination of Candidates for Independent Directors of the Seventh Board of Directors." The relevant situation is hereby announced as follows: I. Board of Directors Election Situation According to the "Articles of Association," the Company's Board of Directors shall consist of 7 directors, including 3 non-independent directors, 1 employee representative director, and 3 independent directors. At the 20th meeting of the Sixth Board of Directors, the Board of Directors agreed to nominate Mr. Li Li, Ms. Li Tan, and Mr. Shan Yu as candidates for non-independent directors of the Seventh Board of Directors; and nominated Mr. Huang Peng, Mr. Yi Ming, and Mr. Pu Hong as candidates for independent directors of the Seventh Board of Directors, with Mr. Huang Peng being a professional accountant. The resumes of the above director candidates are detailed in the appendix. The Nomination Committee of the Board of Directors has reviewed the qualifications of the above director candidates and believes that they are all qualified to serve as directors of a listed company and meet the qualification requirements stipulated in the "Company Law," "Administrative Measures for Independent Directors of Listed Companies," and the "Articles of Association." The nominated independent director candidates, Mr. Huang Peng, Mr. Yi Ming, and Mr. Pu Hong, have obtained independent director qualification certificates recognized by the Shenzhen Stock Exchange. Their qualifications are subject to the review and no objection from the Shenzhen Stock Exchange before submission to the Company's general meeting of shareholders for deliberation. The general meeting of shareholders will elect non-independent directors and independent directors separately using the cumulative voting system. The 6 directors elected by the general meeting of shareholders, together with 1 employee representative director elected by the Company's employee representative assembly or other democratic means, will form the Seventh Board of Directors of the Company. The term of office will be three years from the date of approval by the Company's general meeting of shareholders.
II. Other Explanations The number of director candidates this time complies with the relevant regulations of the "Company Law" and the "Articles of Association." The total number of directors concurrently holding senior management positions and employee representative directors shall not exceed one-half of the total number of directors, and the number of independent directors shall not be less than one-third of the total number of board members. To ensure the normal operation of the Board of Directors, before the new board members take office, the Sixth Board of Directors will continue to perform its duties in accordance with laws, regulations, normative documents, and the "Articles of Association." Hereby announced. Shenzhen Haipu Rui Pharmaceutical Group Co., Ltd. Board of Directors March 31, 2026